Recent News for RTNXF - Renalytix Ai Plc

Date Title
Apr 14 RenalytixAI and Joslin Diabetes Center Build on Proprietary Kidney Biomarker Portfolio for KidneyIntelX Platform
Apr 8 Clinical Utility Study Demonstrates Primary Care Physicians Highly Likely to Order KidneyIntelX to Inform Care Decisions
Apr 5 Multi-Center Study Finds KidneyIntelX 72% More Effective Than Current Standard of Care In Identifying Early-Stage Patients at High Risk for Kidney Disease Progression and Failure
Mar 15 Update on Finalization of MCIT Rule to Provide National Medicare Coverage for FDA Breakthrough Devices and Diagnostics
Mar 10 Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in the Joint Ventures Category
Feb 24 The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health
Feb 23 RenalytixAI to announce Financial Results for six and three months ended December 31, 2020
Feb 4 American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health
Nov 29 Do Hedge Funds Love Renalytix AI plc (RNLX)?
Nov 27 Company News for Nov 27, 2020
Nov 25 Why These 3 Health Care Stocks Are Trading Higher Today
Nov 25 Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies
Nov 25 RenalytixAI Reports Financial Results for First Quarter of Fiscal Year 2021
Back to the Main RTNXF Page...